Monitoring serum and urine osteoprotegrin levens during the treatment of patients with multiple myeloma.

被引：0
|
作者：
Moreb, JS [1 ]
Zucali, JR [1 ]
Roberts, C [1 ]
机构：
[1] Univ Florida, Shands Hosp, Stem Cell Lab, Gainesville, FL 32611 USA
来源：
BLOOD | 2003年 / 102卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5223
引用
收藏
页码：374B / 374B
页数：1
相关论文
共 50 条
  • [1] Monitoring of dendritic cell numbers in patients during the treatment of multiple myeloma.
    Kovarova, L
    Hajek, R
    Svobodnik, A
    Penka, M
    Mayer, J
    BLOOD, 2005, 106 (11) : 356B - 356B
  • [2] Persistently low serum osteoprotegrin levels during the treatment of multiple myeloma patients predicts worse event-free survival
    Moreb, JS
    Zucali, JR
    Roberts, C
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2004, 10 (02) : 70 - 70
  • [3] Free light-chain measurement in serum compared with immunofixation of urine in patients with multiple myeloma.
    Nowrousian, MR
    Brandhorst, D
    Daniels, R
    Sammet, C
    Schuett, P
    Ebeling, P
    Buttkereit, U
    Opalka, B
    Flasshove, M
    Moritz, T
    Seeber, S
    BLOOD, 2003, 102 (11) : 367B - 367B
  • [4] Osteoprotegerin levels are increased in serum of patients with multiple myeloma.
    Corso, A
    Dovio, A
    Sartori, ML
    Rusconi, C
    Klersy, C
    Mangiacavalli, S
    Zappasodi, P
    Varettoni, M
    Angeli, A
    Lazzarino, M
    BLOOD, 2003, 102 (11) : 367B - 367B
  • [5] Serum free light chain immunoassays for monitoring patients with light chain producing and nonsecretory multiple myeloma.
    Bradwell, AR
    Drayson, MT
    Mead, GP
    Galvin, G
    Gasparetto, C
    BLOOD, 2002, 100 (11) : 382B - 382B
  • [6] The serum M-spike and transplant outcome in patients with multiple myeloma.
    Dingli, David
    Pacheco, Jorge M.
    Dispenzieri, Angela
    Hayman, Suzanne R.
    Kumar, Shaji
    Lacy, Martha
    Gastineau, Dennis A.
    Gertz, Morie Abraham
    BLOOD, 2006, 108 (11) : 455B - 455B
  • [7] PCR monitoring following transplantation in multiple myeloma.
    Owen, RG
    Bybee, A
    Haynes, AP
    Johnson, RJ
    Smith, GM
    Child, JA
    Russell, NH
    Gupta, D
    Samson, D
    Morgan, GJ
    BLOOD, 1995, 86 (10) : 818 - 818
  • [8] Treatment of bortezomib increases osteoblast function in patients with multiple myeloma.
    Heider, U
    Kaiser, M
    Müller, C
    Schulz, CO
    Jakob, C
    Zavrski, I
    Eucker, J
    Sterz, J
    Kleeberg, L
    Possinger, K
    Sezer, O
    BLOOD, 2005, 106 (11) : 965A - 965A
  • [9] Liposomal doxorubicin in the treatment of multiple myeloma.
    Jajeh, A
    Zalzaleh, G
    Koko, I
    BLOOD, 2003, 102 (11) : 380B - 380B
  • [10] VASP chemotherapy in patients with multiple myeloma.
    Vidarsson, B
    Olafsdottir, S
    Reykdal, S
    BLOOD, 2005, 106 (11) : 381B - 381B
12345